ArticleJournal for immunotherapy of cancer2019

Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families.

S Yado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.